X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA IPCA LABS PLETHICO PHARMA/
IPCA LABS
 
P/E (TTM) x -1.1 28.0 - View Chart
P/BV x 0.0 2.1 0.8% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 PLETHICO PHARMA   IPCA LABS
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
IPCA LABS
Mar-17
PLETHICO PHARMA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs395643 61.4%   
Low Rs31503 6.2%   
Sales per share (Unadj.) Rs604.4254.4 237.6%  
Earnings per share (Unadj.) Rs32.516.1 202.1%  
Cash flow per share (Unadj.) Rs51.329.8 172.4%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs473.6194.6 243.4%  
Shares outstanding (eoy) m34.08126.20 27.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.42.3 15.7%   
Avg P/E ratio x6.635.7 18.4%  
P/CF ratio (eoy) x4.219.2 21.6%  
Price / Book Value ratio x0.52.9 15.3%  
Dividend payout %06.2 0.0%   
Avg Mkt Cap Rs m7,26272,300 10.0%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m1,5966,960 22.9%   
Avg. sales/employee Rs ThNM2,413.5-  
Avg. wages/employee Rs ThNM523.2-  
Avg. net profit/employee Rs ThNM152.4-  
INCOME DATA
Net Sales Rs m20,59832,106 64.2%  
Other income Rs m386226 171.2%   
Total revenues Rs m20,98432,332 64.9%   
Gross profit Rs m2,8184,448 63.3%  
Depreciation Rs m6421,730 37.1%   
Interest Rs m1,593241 661.6%   
Profit before tax Rs m9692,703 35.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138675 -20.5%   
Profit after tax Rs m1,1072,028 54.6%  
Gross profit margin %13.713.9 98.7%  
Effective tax rate %-14.325.0 -57.2%   
Net profit margin %5.46.3 85.1%  
BALANCE SHEET DATA
Current assets Rs m18,87717,340 108.9%   
Current liabilities Rs m11,8969,559 124.4%   
Net working cap to sales %33.924.2 139.8%  
Current ratio x1.61.8 87.5%  
Inventory Days Days36100 35.8%  
Debtors Days Days19857 347.9%  
Net fixed assets Rs m9,86120,779 47.5%   
Share capital Rs m341252 135.0%   
"Free" reserves Rs m12,33124,499 50.3%   
Net worth Rs m16,13924,553 65.7%   
Long term debt Rs m4,7063,517 133.8%   
Total assets Rs m33,14639,595 83.7%  
Interest coverage x1.612.2 13.2%   
Debt to equity ratio x0.30.1 203.5%  
Sales to assets ratio x0.60.8 76.6%   
Return on assets %8.15.7 142.2%  
Return on equity %6.98.3 83.0%  
Return on capital %12.310.5 117.2%  
Exports to sales %21.448.6 43.9%   
Imports to sales %15.214.2 106.9%   
Exports (fob) Rs m4,40215,617 28.2%   
Imports (cif) Rs m3,1364,571 68.6%   
Fx inflow Rs m4,40215,617 28.2%   
Fx outflow Rs m3,1845,828 54.6%   
Net fx Rs m1,2199,790 12.4%   
CASH FLOW
From Operations Rs m2,4372,764 88.2%  
From Investments Rs m-6,265-1,432 437.6%  
From Financial Activity Rs m2,490-1,591 -156.5%  
Net Cashflow Rs m-1,337-259 516.7%  

Share Holding

Indian Promoters % 82.7 45.9 180.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 11.4 37.7%  
FIIs % 5.5 25.3 21.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 17.4 43.1%  
Shareholders   10,665 36,892 28.9%  
Pledged promoter(s) holding % 85.7 2.1 4,006.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC LTD  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Negative Note; IT Sector Down 2.4%(11:30 am)

After opening the day on a negative note, share markets in India continued to witness losses. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 5-YR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS